FISGENIQ

Serial Number 97155041
Registration 7022284
700

Registration Progress

Application Filed
Dec 3, 2021
Under Examination
Approved for Publication
Jan 24, 2023
Published for Opposition
Jan 24, 2023
Registered
Apr 11, 2023

Trademark Image

FISGENIQ

Basic Information

Serial Number
97155041
Registration Number
7022284
Filing Date
December 3, 2021
Registration Date
April 11, 2023
Published for Opposition
January 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 11, 2023
Registration
Registered
Classes
005

Rights Holder

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

25
Address
THURGAUERSTRASSE 130
GLATTPARK-OPFIKON 8152
CH

Ownership History

TiGenix, S.A.U.

Original Applicant
99
1 Tres Cantos (Madrid) ES

TiGenix, S.A.U.

Owner at Publication
99
1 Tres Cantos (Madrid) ES

TiGenix, S.A.U.

Original Registrant
99
1 Tres Cantos (Madrid) ES

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

New Owner After Registration #1
25
GLATTPARK-OPFIKON CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
1358 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-11)
Due Date
April 11, 2029
Grace Period Ends
October 11, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Jul 10, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 9, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 11, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 11, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 17, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 29, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 28, 2022 ALIE A ASSIGNED TO LIE Loading...
Oct 7, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 20, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 20, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 13, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 7, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; cellular functioning activating agents, biological or bacteriological preparations for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants in the nature of implants comprising living tissue or engineered live cellular tissue in the nature of implants comprising living tissue for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients

Classification

International Classes
005